1. The Undertreatment of Gallbladder Cancer: Gaps in Seeking, Reaching, and Receiving Care

   • Jessica M. Keilson
   • Shishir K. Maithel

   Gastrointestinal Oncology 04 March 2021 Pages: 2925 - 2927

2. Underutilization of Lymphadenectomy for Gallbladder Cancer: A Persistent Problem with Dire Consequences

   • Sameer H. Patel

   Hepatobiliary Tumors 06 March 2021 Pages: 2928 - 2930

3. Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases

   • Daniel Brock Hewitt
   • Timothy M. Pawlik
   • Jordan M. Cloyd

   Hepatobiliary Tumors 21 January 2021 Pages: 2931 - 2933

4. Optimal Management of T1 Gastric Cancer: An Open Question

   • Court Colin
   • Nakauchi Masaya
   • Strong Vivian

   Gastrointestinal Oncology 01 February 2021 Pages: 2934 - 2935

5. Disparities in Gastric Cancer: Can we do better?

   • Deepa Magge
   • Marcus Tan

   Gastrointestinal Oncology 24 March 2021 Pages: 2936 - 2938

6. The Prognostic Role of the Neutrophil to Lymphocyte Ratio at Recurrence in Esophageal Squamous Cell Carcinoma: Challenges and Future Directions

   • Audrey E. Kam
   • Ashiq Masood

   Gastrointestinal Oncology 09 February 2021 Pages: 2939 - 2940

7. Patient-Reported Outcomes Measures in Abdominal Cancer Surgery and Student-Led Surgical Research

   • Augusto León
   • Klaus Puschel
   • Francisca Honold

   Global Health Services Research 31 March 2021 Pages: 2941 - 2943

8. Editorial: Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip

   • Baran D. Sumer

   Head and Neck Oncology 09 February 2021 Pages: 2944 - 2945

9. Elucidating the Efficacy of Pancreatectomy for Renal Cell Metastases Remains Problematic

   • Natasha Leigh
   • William G. Hawkins

   Pancreatic Tumors 03 March 2021 Pages: 2946 - 2948

10. Undertreatment of Gallbladder Cancer: A Nationwide Analysis

    • Marianna V. Papageorge
    • Susanna W. L. de Geus
    • Teviah E. Sachs

    Hepatobiliary Tumors 10 February 2021 Pages: 2949 - 2957

    

11. ASO Author Reflections: Failing to Adhere to Treatment Guidelines in Gallbladder Cancer

    • Marianna V. Papageorge
    • Teviah E. Sachs

    ASO Author Reflections 08 February 2021 Pages: 2958 - 2959

12. Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer

    • Phillip M. Kemp Bohan
    • Anne E. O’Shea
    • Timothy J. Vreeland

    Hepatobiliary Tumors 10 February 2021 Pages: 2960 - 2972

    

13. ASO Author Reflections: Contemporary Analysis of Impact of Lymphadenectomy on Survival in Nonmetastatic Gallbladder Cancer

    • Phillip M. Kemp Bohan
    • Daniel W. Nelson
    • Timothy J. Vreeland

    ASO Author Reflections 09 February 2021 Pages: 2973 - 2974

14. Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy

    • Ryota Nakanishi
    • Eiji Oki
    • Masaki Mori

    Hepatobiliary Tumors 16 January 2021 Pages: 2975 - 2985

    

15. ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis

    • Ryota Nakanishi
    • Eiji Oki
    • Masaki Mori

    ASO Author Reflections 16 March 2021 Pages: 2986 - 2987

16. Liver Transection-First Approach in Hepatopancreatoduodenectomy for Hilar Cholangiocarcinoma: A Safe and Secure Technique for the Early Assessment of Curable Resection and Vascular Reconstruction

    • Takamichi Ishii
    • Satoru Seo
    • Kojiro Taura

    Hepatobiliary Tumors 09 November 2020 Pages: 2988 - 2989

17. Transfissural Approach for Laparoscopic Resection of a Deep Segment 8 Lesion in Contact with the Hepatocaval Confluence

    • Satoshi Ogiso
    • Satoru Seo
    • Kojiro Taura

    Hepatobiliary Tumors 09 November 2020 Pages: 2990 - 2990

18. ASO Author Reflections: Making a Wide Window to the Hepatocaval Confluence for Laparoscopic Resection of a Deep Segment 8 Lesion

    • Satoshi Ogiso
    • Satoru Seo

    ASO Author Reflections 03 January 2021 Pages: 2991 - 2991

19. Local Endoscopic Resection is Inferior to Gastrectomy for Early Clinical Stage T1a and T1b Gastric Adenocarcinoma: A Propensity-Matched Study

    • Sivesh K. Kamarajah
    • Sheraz R. Markar
    • Fadi S. Dahdaleh

    Gastrointestinal Oncology 15 January 2021 Pages: 2992 - 2998

    

20. ASO Author Reflections: Endoscopic Resection or Gastrectomy for Early Clinical Stage T1a or T1b Gastric Adenocarcinoma

    • Sivesh K. Kamarajah
    • Sheraz R. Markar
    • Alexander W. Phillips

    ASO Author Reflections 21 January 2021 Pages: 2999 - 3000

21. Usefulness of Neutrophil to Lymphocyte Ratio at Recurrence for Predicting Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma

    • Shota Hoshino
    • Masashi Takeuchi
    • Yuko Kitagawa

    Thoracic Oncology 10 March 2021 Pages: 3001 - 3008

    

22. Author Reflections: Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio

    • Masashi Takeuchi
    • Shota Hoshino
    • Yuko Kitagawa

    ASO Author Reflections 02 March 2021 Pages: 3009 - 3010

23. Evolution of Esophagectomy for Cancer Over 30 Years: Changes in Presentation, Management and Outcomes

    • S. Michael Griffin
    • Rhys Jones
    • Alexander W. Phillips

    Thoracic Oncology Open access 18 October 2020 Pages: 3011 - 3022

    

24. ASO Author Reflections: 30 Years of Esophagectomy

    • A. W. Phillips
    • S. K. Kamarajah
    • S. M. Griffin

    ASO Author Reflections Open access 18 March 2021 Pages: 3023 - 3024

25. Impact of Examined Lymph Node Count for Esophageal Squamous Cell Carcinoma in Patients who Underwent Right Transthoracic Esophagectomy

    • Yu-Zhen Zheng
    • Xiao-Qiang Li
    • Jian-Hua Fu

    Thoracic Oncology 18 October 2020 Pages: 3025 - 3033

    

26. Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy

    • Roberta La Mendola
    • Maria Bencivenga
    • Simone Giacopuzzi

    Thoracic Oncology Open access 19 October 2020 Pages: 3034 - 3043

    

27. ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event

    • Roberta La Mendola
    • Maria Bencivenga
    • Simone Giacopuzzi

    ASO Author Reflections 11 November 2020 Pages: 3044 - 3045

28. Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer

    • Taichi Matsubara
    • Shinkichi Takamori
    • Tatsuro Okamoto

    Thoracic Oncology 21 October 2020 Pages: 3046 - 3054

    

29. ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC

    • Taichi Matsubara
    • Tatsuro Okamoto

    ASO Author Reflections 23 October 2020 Pages: 3055 - 3056

30. Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma

    • Akifumi Nakamura
    • Nobuyuki Kondo
    • Seiki Hasegawa

    Thoracic Oncology 29 October 2020 Pages: 3057 - 3065

    

31. Resection of Parapharyngeal Space Tumors Located in the Prestyloid Compartment: Efficacy of the Cervical Approach

    • Takashi Matsuki
    • Isaku Okamoto
    • Kouki Miura

    Thoracic Oncology 03 November 2020 Pages: 3066 - 3072

    

32. ASO Author Reflections: What is the Best Surgical Approach for Benign Tumors Arising from the Prestyloid Compartment in the Parapharyngeal Space?

    • Takashi Matsuki

    ASO Author Reflections 30 October 2020 Pages: 3073 - 3074

33. Multicenter Prospective Cohort Study of the Patient-Reported Outcome Measures PRO-CTCAE and CAT EORTC QLQ-C30 in Major Abdominal Cancer Surgery (PATRONUS): A Student-Initiated German Medical Audit (SIGMA) Study

    • CHIR-Net SIGMA Study Group*
    • André L. Mihaljevic

    Global Health Services Research Open access 08 March 2021 Pages: 3075 - 3089

    

34. ASO Author Reflections: The Magic of Clinical Research—The Student-Led PATRONUS Study Unveils Two Patient-Reported Outcome Measures for Use in Surgical Oncology

    • The CHIR-Net SIGMA Study Group
    • André L. Mihaljevic

    ASO Author Reflections Open access 22 February 2021 Pages: 3090 - 3091

35. Validation of the American Joint Committee on Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip

    • Amanda E. Yung
    • Michael S. Que
    • Sydney Ch’ng

    Head and Neck Oncology 02 January 2021 Pages: 3092 - 3099

    

36. Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma

    • Giuseppe Malleo
    • Roberto Salvia
    • Giovanni Butturini

    Pancreatic Tumors Open access 11 February 2021 Pages: 3100 - 3108

    

37. ASO Author Reflections: Long-Term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma

    • Giuseppe Malleo
    • Roberto Salvia
    • Giovanni Butturini

    ASO Author Reflections 09 February 2021 Pages: 3109 - 3110

38. Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology

    • Elizabeth J. Olecki
    • Kelly A. Stahl
    • Niraj J. Gusani

    Pancreatic Tumors 31 January 2021 Pages: 3111 - 3122

    

39. ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients

    • Elizabeth J. Olecki
    • Niraj J. Gusani

    ASO Author Reflections 22 February 2021 Pages: 3123 - 3123

40. ASO Visual Abstract: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival in Those with Low-Risk Pathology

    • Elizabeth J. Olecki
    • Kelly A. Stahl
    • Niraj J. Gusani

    ASO Visual Abstract 18 March 2021 Pages: 3124 - 3124

    

41. An Aggressive Approach to Locally Confined Pancreatic Cancer: Defining Surgical and Oncologic Outcomes Unique to Pancreatectomy with Celiac Axis Resection (DP-CAR)

    • Ryan K. Schmocker
    • Michael J. Wright
    • Richard A. Burkhart

    Pancreatic Tumors 13 October 2020 Pages: 3125 - 3134

    

42. Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma

    • Takuro Yamaguchi
    • Kenichiro Uemura
    • Taijiro Sueda

    Pancreatic Tumors 30 October 2020 Pages: 3135 - 3144

    

43. ASO Author Reflections: Clinical Implications of Circulating Tumor DNA in Pancreatic Cancer Patients

    • Takuro Yamaguchi
    • Kenichiro Uemura
    • Shinya Takahashi

    ASO Author Reflections 03 January 2021 Pages: 3145 - 3146

44. The Impact of Residential Segregation on Pancreatic Cancer Diagnosis, Treatment, and Mortality

    • Barbara Aldana Blanco
    • Michael Poulson
    • Teviah E. Sachs

    Pancreatic Tumors 01 November 2020 Pages: 3147 - 3155

    

45. ASO Author Reflections: The Impact of Residential Segregation on Pancreatic Cancer Diagnosis, Treatment, and Mortality

    • Michael R. Poulson
    • Barbara Aldana Blanco
    • Teviah E. Sachs

    ASO Author Reflections 25 October 2020 Pages: 3156 - 3156

46. Decompositions of the Contribution of Treatment Disparities to Survival Disparities in Stage I–II Pancreatic Adenocarcinoma

    • Douglas S. Swords
    • Courtney L. Scaife

    Pancreatic Tumors 03 November 2020 Pages: 3157 - 3168

    

47. ASO Author Reflections: Using Causal Mediation Analysis to Understand the Proportion of Survival Disparities Mediated by Potentially Modifiable Treatment Factors

    • Douglas S. Swords
    • Courtney L. Scaife

    ASO Author Reflections 09 November 2020 Pages: 3169 - 3170

48. The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis

    • Piera Leon
    • Fabio Giannone
    • Fabrizio Panaro

    Pancreatic Tumors 06 November 2020 Pages: 3171 - 3183

    

49. ASO Author Reflections: Exploring the Oncologic Impact of Pancreatic Fistula after Distal Pancreatectomy for Ductal Adenocarcinoma

    • Piera Leon
    • Fabrizio Panaro

    ASO Author Reflections 21 November 2020 Pages: 3184 - 3185

50. Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis

    • Wilson Luiz da Costa Jr.
    • Hop S. Tran Cao
    • Nader N. Massarweh

    Pancreatic Tumors 10 November 2020 Pages: 3186 - 3195